Remote Source Access refers to the ability to view, retrieve, or interact with source documents and data from a location different from where the information is physically stored. In clinical research, this typically involves accessing patient records, case report forms, or other study-related documents through secure electronic systems or networks.
This approach allows authorized personnel to review and verify clinical trial data without the need for on-site visits. Remote Source Access enhances efficiency in clinical trials by reducing travel costs, speeding up data verification processes, and enabling real-time monitoring of study progress and patient safety.
Remote Source Access is crucial in clinical research as it significantly enhances the efficiency and quality of data management and monitoring processes. It allows for timely review of study data, enabling faster identification and resolution of potential issues, which is essential for maintaining the integrity and safety of clinical trials.
Furthermore, Remote Source Access facilitates collaboration among geographically dispersed research teams and sponsors. This capability is particularly valuable in multi-center and global studies, where it can reduce the need for frequent on-site visits, thereby lowering costs and accelerating study timelines while maintaining rigorous oversight.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant